APA (7th ed.) Citation

Triantafyllidi, E., & Triantafillidis, J. K. (2022). Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Triantafyllidi, Eleni, and John K. Triantafillidis. Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer. MDPI AG, 2022.

MLA (9th ed.) Citation

Triantafyllidi, Eleni, and John K. Triantafillidis. Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer. MDPI AG, 2022.

Warning: These citations may not always be 100% accurate.